🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, asserting the companies concealed potential risks that the medication created to pediatric neurological development.

The lawsuit comes a month after President Donald Trump advocated an unproven link between taking Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is taking legal action against J&J, which previously sold the drug, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he said they "deceived the public by gaining financially from suffering and promoting medication without regard for the risks."

The company says there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These companies deceived for years, knowingly endangering countless individuals to line their pockets," the attorney general, a Republican, said.

The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the well-being of American women and children."

On its official site, Kenvue also mentioned it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a established connection between using paracetamol and autism spectrum disorder."

Groups representing doctors and healthcare providers share this view.

ACOG has declared paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to address discomfort and fever, which can create serious health risks if ignored.

"In over twenty years of investigation on the use of paracetamol in pregnancy, zero credible investigations has successfully concluded that the usage of paracetamol in any trimester of pregnancy causes neurological conditions in young ones," the organization commented.

This legal action cites current declarations from the previous government in arguing the medication is reportedly hazardous.

Recently, Trump caused concern from public health officials when he instructed pregnant women to "fight like hell" not to consume Tylenol when unwell.

The FDA then released a statement that physicians should consider limiting the use of Tylenol, while also declaring that "a proven link" between the drug and autism in children has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had pledged in April to undertake "comprehensive study program" that would establish the origin of autism in a matter of months.

But specialists warned that discovering a single cause of autism - believed by scientists to be the result of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a type of enduring cognitive variation and condition that impacts how persons encounter and relate to the surroundings, and is diagnosed using physician assessments.

In his legal document, the attorney general - aligned with the former president who is campaigning for US Senate - alleges the manufacturer and J&J "intentionally overlooked and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "eliminate any marketing or advertising" that asserts acetaminophen is safe for expectant mothers.

This legal action mirrors the grievances of a group of guardians of young ones with autism spectrum disorder and ADHD who filed suit against the manufacturers of acetaminophen in two years ago.

Judicial authorities rejected the case, declaring investigations from the plaintiffs' authorities was not conclusive.